Finally, in order to be more practical and persuasive in clinical transformation, we need to explore the mechanism of why LSM5 and LSM8 can be biomarker of chemoresistance in GC, explaining it from a deep perspective and further exploring the way to achieve clinical intervention. This evidence concerns the gene LSM8 and gastric cancer.